Skip to content

    Investment Firms in Basel, Switzerland

    Situated within the trinational Upper Rhine region, it is a globally significant hub for life sciences and industrial biotechnology, heavily influenced by the presence of major pharmaceutical corporations. This deep industry expertise anchors a venture capital ecosystem that is particularly specialized in supporting high-growth, late-stage companies in biotech and related sectors. Its strength is further amplified by close collaboration with local universities and research institutes, which provide a steady pipeline of scientific innovation.

    Basel, Switzerland's investment landscape is shaped by Healthcare, with 63% of its 8 investment firms focused on this sector. The most active by portfolio size are Roche Venture Fund, Novartis Pharma AG, and Syngenta Group Ventures.

    Healthcare dominates the investment landscape in Basel, with 63% of investment firms focused on this sector.

    Basel is a particularly strong hub for early-stage investing, with over 88% of investment firms active at the Seed or Pre-Seed stage.

    Last updated: 20 October 2026

    Investment Firms

    8

    Total Investments

    186

    Top Sector

    Healthcare

    Top Stage

    Series A

    Top Investment Sectors in Basel

    The most popular sector focus among Basel investment firms is Healthcare, with 5 investment firms (63%) investing in the space. This is followed by Biotech & Life Sciences (4), Fintech (2), PropTech (2), Food & Agriculture (1).

    Investment Stages in Basel

    Basel investment firms are most active at the Series A stage (8 investment firms). This is followed by Series B (7), Seed (7), Series C (4), Series D (3).

    Frequently Asked Questions

    International